Dronabinol
Product manufactured by Par Pharmaceutical, Inc.
Indications and Purposes
Indications And Usage Dronabinol Capsules Are Indicated For The Treatment Of: Anorexia Associated With Weight Loss In Patients With Aids; And Nausea And Vomiting Associated With Cancer Chemotherapy In Patients Who Have Failed To Respond Adequately To Conventional Antiemetic Treatments. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
Name | Structure | ZINC ID(s) |
---|---|---|
1. Dronabinol |
|
ZINC1530625 |